CNS Pharmaceuticals Launches Strategy to Build Neurology and Oncology Drug Pipeline
Houston, Texas, United States — March 11, 2026 Biotechnology company CNS Pharmaceuticals has announced the launch of a new...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Houston, Texas, United States — March 11, 2026 Biotechnology company CNS Pharmaceuticals has announced the launch of a new...
New York, United States — March 10, 2026 Biotechnology company Dianthus Therapeutics has announced the pricing of an upsized...
New York, United States & Waltham, Massachusetts – March 9, 2026 Dianthus Therapeutics, Inc., a clinical-stage biotechnology company focused...
